Disease Characteristics and Burden in Patients With Atopic Dermatitis: Insights From Two Phase 3 Studies of Ruxolitinib Cream

被引：0
|
作者：
Simpson, Eric [1 ]
Lee, Mark [2 ]
Brar, Kanwaljit [3 ]
Kuligowski, Michael [4 ]
Venturanza, May [4 ]
Sun, Kang [4 ]
Toth, Darryl [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Progress Clin Res, San Antonio, TX USA
[3] NYU, Grossman Sch Med, Hassenfeld Childrens Hosp, New York, NY USA
[4] Incyte Corp, Wilmington, DE USA
[5] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
108
引用
收藏
页码：AB35 / AB35
页数：1
相关论文
共 50 条
  • [1] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Kuligowski, Michael E.
    Kallender, Howard
    Sun, Kang
    Ren, Haobo
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1008 - 1016
  • [2] Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
    Papp, K.
    Szepietowski, J.
    Kircik, L.
    Toth, D.
    Eichenfield, L.
    Forman, S.
    Kuligowski, M.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S184 - S184
  • [3] Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121
  • [4] Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
    Xiaohua Gong
    Xuejun Chen
    Michael E. Kuligowski
    Xing Liu
    Xiang Liu
    Evan Cimino
    Ryan McGee
    Swamy Yeleswaram
    American Journal of Clinical Dermatology, 2021, 22 : 555 - 566
  • [5] Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
    Gong, Xiaohua
    Chen, Xuejun
    Kuligowski, Michael E.
    Liu, Xing
    Liu, Xiang
    Cimino, Evan
    McGee, Ryan
    Yeleswaram, Swamy
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 555 - 566
  • [6] Long-term safety and disease control with Ruxolitinib cream in atopic dermatitis: Pooled results from two phase 3 studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Ren, H.
    Simpson, E. L.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 43 - 43
  • [7] Effects of ruxolitinib cream on work productivity and activity impairment in patients with atopic dermatitis: Pooled results from two phase 3 studies
    Eichenfield, Lawrence F.
    Silverberg, Jonathan I.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Augustin, Matthias
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB179 - AB179
  • [8] Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB158 - AB158
  • [9] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Thaci, Diamant
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB160 - AB160
  • [10] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E134 - E135
12345